PAVmed Inc. (PAVM) Misses Q2 EPS by 5c, misses on revenue

PAVmed Inc. (NASDAQ: PAVM) reported Q2 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $525 thousand.

For earnings history and earnings-related data on PAVmed Inc. (PAVM) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Morgan Stanley upgrades CDW on stronger AI-driven server demand